Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6990N
Kier Group PLC
22 January 2019
 

22 January 2019

 

KIER GROUP PLC - TRADING UPDATE

 

Kier Group plc ("the Group"), a leading infrastructure services, buildings and developments & housing group, announces its trading update covering the period since its previous trading update of 16 November 2018. The Group will announce its half-year results on 21 March 2019.

 

Highlights include:

· On track to meet its FY19 expectations;

· Average month-end net debt of c.£370m (H2 FY18: £410m), reflecting the impact of the recent rights issue; and

· The Future Proofing Kier programme (the "FPK programme") is progressing well.

 

TradingThe Board is confident that the Group will meet its FY19 expectations, with the full-year results being weighted towards the second half of the financial year, as usual.

 

During the period, the Infrastructure Services and Buildings businesses won a number of new contract awards and now have 100% visibility of the forecast revenue for FY19 and an order book of more than £10bn.

 

Examples of recent key awarded contracts include:

· the renewal of a three-year c.£70m utility services contract in the south west of England;

· over £500m of regional building projects secured during November and December, including a major office development for Argent at King's Cross in London, a new research facility for the Pirbright Institute in Surrey, a flagship development for the Royal College of Art and a new hospital for Frimley Health NHS Foundation Trust; and

· being appointed to three lots on the North West Construction Hub three-year £1.5bn framework.

 

In the Developments & Housing businesses, we have experienced a stable housing market, evidenced by a current sales rate of 0.8 units per sales outlet per week (2018: 0.7). In property developments, we have sold all schemes which were forecast to be sold in the period, which highlights the strength of our regional development activities.

 

Future Proofing Kier programme

As previously reported, the costs of implementing the FPK programme in the first half of the financial year have exceeded the savings by £10m. The full-year FY19 position is still expected to be earnings and cashflow neutral and the programme is progressing well.

 

Balance Sheet

The Group's balance sheet at 31 December 2018 has been strengthened following the receipt of the £250m net cash proceeds of the recent rights issue and the Group remains on track to report a net cash position at the year-end (30 June 2019). As at 31 December 2018, the Group's net debt was c.£130m (31 December 2017: £239m), reflecting the rights issue proceeds and the acceleration of supply chain payments, as expected. The average month-end net debt for the six months ended 31 December 2018 was c.£370m, as compared with £410m for the six months ended 30 June 2018.

 

- ENDS -

 

For further information, please contact: 

Louise Turner-Smith, Kier investor relations

+44 (0)7976 790012

Kier press office

+44 (0)1767 355903

Nick Hasell, FTI Consulting

+44 (0)203 727 1340

 

 

Cautionary statement

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUGGGUPBPGG
Date   Source Headline
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:33 amRNSTransaction in Own Shares
21st Jan 20252:11 pmRNSDirector/PDMR Shareholding
21st Jan 20257:01 amRNSLaunch of £20m share buyback programme
21st Jan 20257:00 amRNSTrading Update
2nd Jan 202511:05 amRNSBlock listing Interim Review
20th Dec 202411:20 amRNSDirector/PDMR Shareholding
13th Dec 20241:11 pmRNSDirector/PDMR Shareholding
10th Dec 20243:34 pmRNSDirector/PDMR Shareholding
6th Dec 202410:37 amRNSHolding(s) in Company
5th Dec 20249:14 amRNSNotification of Change of Director Details
4th Dec 20244:43 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:39 pmRNSTotal Voting Rights
20th Nov 20244:03 pmRNSDirector/PDMR Shareholding
18th Nov 202411:47 amRNSHolding(s) in Company
14th Nov 20242:45 pmRNSResult of AGM
14th Nov 20247:00 amRNSAGM Trading Update
13th Nov 20242:58 pmRNSHolding(s) in Company
8th Nov 202410:36 amRNSDirector/PDMR Shareholding
4th Nov 20245:28 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20243:21 pmRNSDirector/PDMR Shareholding
29th Oct 202411:26 amRNSBlock Listing Application
22nd Oct 202412:47 pmRNSDirector/PDMR Shareholding
16th Oct 20244:23 pmRNSAnnual Financial Report Amendment
14th Oct 20242:53 pmRNSDirector/PDMR Shareholding
4th Oct 202412:00 pmRNSAnnual Financial Report
1st Oct 202412:09 pmRNSTotal Voting Rights
23rd Sep 20242:03 pmRNSHolding(s) in Company
23rd Sep 202410:21 amRNSDirector/PDMR Shareholding
12th Sep 20247:05 amRNSDirectorate Change
12th Sep 20247:00 amRNSFY24 Results
6th Sep 20242:29 pmRNSHolding(s) in Company
2nd Sep 202412:33 pmRNSTotal Voting Rights
22nd Aug 20241:51 pmRNSDirector/PDMR Shareholding
12th Aug 20245:32 pmRNSNotice of Results and Presentations
1st Aug 20249:59 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSFull Year 2024 Trading Update
16th Jul 20243:38 pmRNSHolding(s) in Company
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:28 amRNSTotal Voting Rights
28th Jun 20244:34 pmRNSDirector/PDMR Shareholding
27th Jun 20244:20 pmRNSHolding(s) in Company
20th Jun 202411:53 amRNSDirector/PDMR Shareholding
13th Jun 20243:10 pmRNSDirector/PDMR Shareholding
7th Jun 202410:41 amRNSDirector/PDMR Shareholding
4th Jun 20244:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.